Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.83 USD | +0.35% |
|
-3.08% | -63.01% |
06-27 | GT Biopharma Says FDA Clears Investigational New Drug Application for Cancer Drug GTB-3650 | MT |
06-27 | GT Biopharma Shares Rise on FDA Clearance for Cancer-Drug Study | DJ |
1st Jan change | Capi. | |
---|---|---|
-63.01% | 6.1M | |
+55.32% | 815B | |
+42.97% | 641B | |
-6.75% | 352B | |
+13.56% | 314B | |
+10.68% | 303B | |
+16.19% | 242B | |
+2.17% | 224B | |
+13.34% | 218B | |
+8.48% | 168B |
- Stock Market
- Equities
- GTBP Stock
- News GT Biopharma, Inc.
- GT Biopharma CEO Anthony Cataldo, CFO Michael Handelman Step Down to Pursue Other Interests; Shares Decline